Integrative omics analysis reveals insights into small colony variants of Staphylococcus aureus induced by sulfamethoxazole-trimethoprim

Jingwen Zhou,Chunyan He,Han Yang,Wen Shu,Qingzhong Liu
DOI: https://doi.org/10.1186/s12866-024-03364-8
IF: 4.465
2024-06-16
BMC Microbiology
Abstract:Long-term treatment with trimethoprim-sulfamethoxazole (SXT) can lead to the formation of small-colony variants (SCVs) of Staphylococcus aureus . However, the mechanism behind SCVs formation remains poorly understood. In this study, we explored the phenotype and omics-based characterization of S. aureus SCVs induced by SXT and shed light on the potential causes of SCV formation.
microbiology
What problem does this paper attempt to address?
The problem this paper attempts to address is the mechanism by which long-term use of trimethoprim-sulfamethoxazole (SXT) treatment leads to the formation of Small Colony Variants (SCVs) of Staphylococcus aureus (S. aureus). Although SCVs are clinically associated with recurrent and chronic refractory infections, the mechanism of their formation is not fully understood. Therefore, this study explores the phenotypic characteristics and potential formation mechanisms of SXT-induced S. aureus SCVs through multi-omics analyses (genomics, transcriptomics, and metabolomics). Specifically, the main issues of the study include: 1. **Phenotypic characteristics of SCVs**: Investigating the growth characteristics and antibiotic resistance of SCVs through methods such as growth kinetics, antibiotic sensitivity testing, and nutritional deficiency testing. 2. **Genomic variations**: Identifying gene mutations between SCVs and their parent strains through whole-genome sequencing, particularly genes related to adhesion, ribonucleotide phosphate transfer, transport pathways, and phage-encoded proteins. 3. **Transcriptomic changes**: Analyzing differentially expressed genes between SCVs and parent strains through RNA sequencing, especially those involved in metabolic pathways, amino acid metabolism, and ABC transporters. 4. **Metabolomic changes**: Identifying differentially expressed metabolites between SCVs and parent strains through metabolomic analysis, particularly those related to energy metabolism and nucleic acid synthesis. Through these multi-omics analyses, the study aims to reveal the molecular mechanisms of SXT-induced S. aureus SCVs formation, providing clues for developing new strategies to combat SCVs infections.